Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Ocugen Stock Surges 75% Year to Date: What′s in Store for 2026? (Zacks) +++ OCUGEN Aktie +3,13%

TELIX Aktie

 >TELIX Aktienkurs 
6.776 EUR    -1.7%    (Tradegate)
Ask: 6.784 EUR / 737 Stück
Bid: 6.612 EUR / 757 Stück
Tagesumsatz: 10025 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
TELIX Aktie über LYNX handeln
>TELIX Performance
1 Woche: +1,0%
1 Monat: -18,0%
3 Monate: -18,7%
6 Monate: -50,7%
1 Jahr: -53,5%
laufendes Jahr: -54,0%
>TELIX Aktie
Name:  TELIX PHARMACEUTICALS LTD
Land:  Australien
Sektor:  Gesundheit
ISIN/ Wkn:  AU000000TLX2 / A2H7JK
Symbol/ Ticker:  T3X (Frankfurt)
Kürzel:  FRA:T3X, ETR:T3X, T3X:GR
Index:  -
Webseite:  https://telixpharma.com/
Profil:  Telix Pharmaceuticals Limited is a global, commerc..
>Volltext..
Marktkapitalisierung:  2291.74 Mio. EUR
Unternehmenswert:  2471.62 Mio. EUR
Umsatz:  577.91 Mio. EUR
EBITDA:  36.91 Mio. EUR
Nettogewinn:  9.3 Mio. EUR
Gewinn je Aktie:  0.03 EUR
Schulden:  356.5 Mio. EUR
Liquide Mittel:  176.57 Mio. EUR
Operativer Cashflow:  17.83 Mio. EUR
Bargeldquote:  0.69
Umsatzwachstum:  43.72%
Gewinnwachstum:  -69.63%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  TELIX
Letzte Datenerhebung:  29.12.25
>TELIX Kennzahlen
Aktien/ Unternehmen:
Aktien: 338.76 Mio. St.
Frei handelbar: 79.15%
Leerverk. Aktien: -
Rückkaufquote: -0.03%
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Strong buy
Kursziel: 125.57%
Bewertung:
KGV: 263
KGV lG: 179.6
KUV: 3.81
KBV: 6.41
PEG-Ratio: -
EV/EBITDA: 66.96
Rentabilität:
Bruttomarge: 58.05%
Gewinnmarge: 1.61%
Operative Marge: 4.51%
Managementeffizenz:
Gesamtkaprendite: 1.3%
Eigenkaprendite: 3.18%
>TELIX Peer Group

Es sind 56 Aktien bekannt.
 
29.12.25 - 16:54
 Berger Montague: TELIX PHARMACEUTICALS LTD. (TLX) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action (Newsfile)
 
Philadelphia, Pennsylvania--(Newsfile Corp. - December 29, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceutica......
29.12.25 - 15:42
 Faruqi & Faruqi LLP: INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals (Newsfile)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their OptionsIf you purchased or acquire......
29.12.25 - 15:03
 Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) - January 9, 2026 Deadline to Join - Contact The Gross Law Firm (PR Newswire)
 
NEW YORK, Dec. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). Shareholders who purchased shares of TLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
29.12.25 - 08:42
 Telix Pharmaceuticals Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - TLX (PR Newswire)
 
LOS ANGELES, Dec. 29, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Telix Pharmaceuticals Limited ("Telix" or "the Company") (NASDAQ: TLX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated......
28.12.25 - 12:30
 Faruqi & Faruqi LLP: DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals (Newsfile)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Telix to Contact Him Directly to Discuss Their OptionsIf you purchased or acquire......
27.12.25 - 21:57
 21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures (PR Newswire)
 
Partner Reed Kathrein Scrutinizing Alleged Misstatements on Prostate Cancer Drug TLX591 Progress and Third-Party Manufacturing SAN FRANCISCO, Dec. 27, 2025 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in Telix Pharmaceuticals Ltd.......
26.12.25 - 21:03
 TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm (PR Newswire)
 
NEW YORK, Dec. 26, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the "Class Period"), of the important January......
26.12.25 - 15:03
 Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX) Seeking Recovery for Investors - Contact Levi & Korsinsky (PR Newswire)
 
NEW YORK, Dec. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. ("Telix Pharmaceuticals Ltd." or the "Company") (NASDAQ: TLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix......
25.12.25 - 14:30
 Faruqi & Faruqi LLP: TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 (Newsfile)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in Telix to Contact Him Directly to Discuss Their OptionsIf you purchased or acquire......
24.12.25 - 20:54
 21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures (PR Newswire)
 
Partner Reed Kathrein Scrutinizing Alleged Misstatements on Prostate Cancer Drug TLX591 Progress and Third-Party Manufacturing Deficiencies (Form 483) SAN FRANCISCO, Dec. 24, 2025 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in......
24.12.25 - 20:54
 Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, Dec. 24, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX). IF YOU SUFFERED A LOSS ON YOUR......
23.12.25 - 21:42
 Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
 
LOS ANGELES, Dec. 23, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ: TLX) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO......
23.12.25 - 18:18
 Berger Montague: CLASS ACTION REMINDER: Berger Montague Advises Telix Pharmaceuticals Ltd. (TLX) Investors to Inquire About a Securities Fraud Lawsuit by January 9, 2026 (Newsfile)
 
Philadelphia, Pennsylvania--(Newsfile Corp. - December 23, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceutica......
23.12.25 - 16:51
 SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals (PR Newswire)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Telix between February 21, 2025 and August 28, 2025 and would like to......
23.12.25 - 15:03
 Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact Levi & Korsinsky about pending Class Action - TLX (PR Newswire)
 
NEW YORK, Dec. 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Telix Pharmaceuticals Ltd. ("Telix Pharmaceuticals Ltd." or the "Company") (NASDAQ: TLX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Telix......
22.12.25 - 18:42
 Berger Montague: TLX CLASS ACTION NOTICE: Berger Montague Encourages Telix Pharmaceuticals Ltd. (TLX) Investors to Inquire About a Securities Fraud Class Action (Newsfile)
 
Philadelphia, Pennsylvania--(Newsfile Corp. - December 22, 2025) - National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceutica......
22.12.25 - 16:18
 Faruqi & Faruqi LLP: TLX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals (Newsfile)
 
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Telix To Contact Him Directly To Discuss Their OptionsIf you purchased or acquire......
22.12.25 - 15:01
 21% TLX PLUNGE: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures (PR Newswire)
 
Partner Reed Kathrein Scrutinizing Alleged Misstatements on Prostate Cancer Drug TLX591 Progress and Third-Party Manufacturing Deficiencies (Form 483) SAN FRANCISCO, Dec. 22, 2025 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is issuing a reminder to investors in......
22.12.25 - 11:24
 Just The Facts: Archtis, Critical Resources, Telix Pharmaceuticals, Dimerix (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
22.12.25 - 10:01
 The Gross Law Firm Notifies Telix Pharmaceuticals Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline - TLX (PR Newswire)
 
NEW YORK, Dec. 22, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Telix Pharmaceuticals Ltd. (NASDAQ: TLX). Shareholders who purchased shares of TLX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Ich bete, um zu glauben. Glaube ich. - Peter Esterházy
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!